Donor Eggs IVF Services Market by Cycle Type (Fresh Donor Egg IVF Cycle and Frozen Donor Egg IVF Cycle), by End User (Fertility Clinics, Surgical Centers, Hospital, Clinical Research Institutes)- Global Opportunity Analysis and Industry Forecast, 2020 - 2030

Abstract
“The Global Donor Eggs IVF Services Market size was valued at USD 1.95 billion in 2019, is predicted an elevation of USD 4.83 billion by 2030, witnessing a CAGR of 8.6% from 2020-2030.

Donor eggs IVF service is type of an Assisted Reproduction Treatment, where egg donated by a healthy female donor, is fertilized in vitro with a healthy sperm, outside the body, in favorable laboratory conditions, assisting it to develop into an embryo, that is later implanted into the uterus of desiring women for further development. Donor egg IVF services are majorly adopted by women having endometriosis or other reproductive health issues.

Market Dynamics and Trends

The global donor eggs IVF services market is witnessing a substantial growth, owing to technological advancements in the medical sector, increasing awareness about ARTs, upsurge in gamete donations, growing number of IVF clinics as well as increase in disposable incomes. Besides, factors such as delayed pregnancies among women, drastically changing lifestyles, increasing incidences of infertility issues, rising levels of stress are responsible for propelling the market growth.

Furthermore, high rates of obesity, food-habits, increased consumption of alcohol and surge in cigarette-smoking, are expected to foster the growth of the donor eggs IVF services market throughout the forecast period.

However, society restraints, cost constraints and complications in the IVF procedures may impede the donor eggs IVF services market growth during the forecast period.

Moreover, technological advancements associated with IVF services, modernizing healthcare infrastructures, increase in IVF clinics, and high success rate of the IVF treatment are expected to create lucrative opportunities in the global donor eggs IVF services market in coming future.

Market Segmentations and Scope of the Study:

The global donor eggs IVF services market share analysis is based on cycle type, end user and geography. Based on cycle type, the market is segmented into fresh donor egg IVF cycle and frozen donor egg IVF cycle. Based on end user, the market is divided into fertility clinics, hospital, surgical centers, and clinical research institutes. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America is expected to dominate the global donor eggs IVF services market, holding the highest market shares. This is attributable to advanced healthcare infrastructures, high success rates of IVF treatments, availability of skilled doctors, advanced services as well as more acceptance towards such procedures.

Asia Pacific projects a rapid development with gradual increase in the market share, owing to drastically changing lifestyles, increase in disposable incomes, adoption of advanced technologies and ongoing developments in healthcare infrastructures.

Competitive Landscape

The donor eggs IVF services market is competitive in nature and consist of several market players contributing to the overall market size. Some of the key players include TMC Fertility Centre, Fairfax Egg Bank Inc, SAFE Fertility Center, KL Fertility & Gynecology Centre, Morpheus Life Sciences Pvt. Ltd, Shanghai Ji Ai Genetics & IVF Institute, Flinders Reproductive Medicine Pty Ltd, Thomson Medical Pte. Ltd, Virtus Health Limited, Genea Oxford Fertility Limited, and others.

There are many technological advancements taking place in the medical sector, that tend to fuel-up the overall growth of the global donor eggs IVF services market. For instance, in April 2019, the Society for Assisted Reproductive Technology (SART), an affiliated American Society for Reproductive Medicine, revealed its statistical data, that showed an increase in the use of cryopreservation for fertility preservation in IVF procedures. Furthermore, the most significant trend observed in the process was increase in the number of eggs freezing cycles, both for donor egg banking and for fertility preservation.

KEY MARKET SEGMENTS:
• Global Donor Eggs IVF Services market – By Cycle Type
- Fresh Donor Egg IVF Cycle
- Frozen Donor Egg IVF Cycle
• Global Donor Eggs IVF Services market – By End User
- Fertility Clinics
- Hospital
- Surgical Centres
- Clinical Research Institutes
• Global Donor Eggs IVF Services market –By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- Ireland
- UK
- Germany
- France
- Italy
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Australia
- New Zealand
- Malaysia
- Thailand
- Rest of Asia-Pacific
- RoW
- Latin America
- Middle east
- Africa”

Content
1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. RESEARCH METHODOLOGY
1.2.1 SECONDARY RESEARCH
1.2.2 DATA ANALYSIS FRAMEWORK
1.2.3 MARKET SIZE ESTIMATION
1.2.4 FORECASTING
1.2.5 PRIMARY RESEARCH AND DATA VALIDATION
2. MARKET SNAPSHOT, 2019-2030 MILLION USD
2.1. MARKET SNAPSHOT
3. PORTER’S FIVE FORCE MODEL ANALYSIS
4. MARKET DYNAMICS
4.1. GROWTH DRIVERS
4.1.1 DRIVER 1
4.1.2 DRIVER 2
4.1.3 DRIVER 3
4.1.4 DRIVER 4
4.2. CHALLENGES
4.2.1 CHALLENGE 1
4.2.2 CHALLENGE 2
4.3. OPPORTUNITIES
4.3.1 OPPORTUNITY 1
4.3.2 OPPORTUNITY 2
5. GLOBAL DONOR EGG IVF SERVICES MARKET, BY CYCLE TYPE
5.1. OVERVIEW
5.2. FRESH DONOR EGG IVF CYCLES
5.2.1 FRESH DONOR EGG IVF CYCLES MARKET, BY REGION
5.2.1.1 North America Fresh Donor Egg IVF Cycles Market, By Country
5.2.1.2 Europe Fresh Donor Egg IVF Cycles Market, By Country
5.2.1.3 Asia-Pacific Fresh Donor Egg IVF Cycles Market, By Country
5.2.1.4 Rest of World Fresh Donor Egg IVF Cycles Market, By Country
5.3. FROZEN DONOR EGG IVF CYCLES
5.3.1 FROZEN DONOR EGG IVF CYCLES MARKET, BY REGION
5.3.1.1 North America Frozen Donor Egg IVF Cycles Market, By Country
5.3.1.2 Europe Frozen Donor Egg IVF Cycles Market, By Country
5.3.1.3 Asia-Pacific Frozen Donor Egg IVF Cycles Market, By Country
5.3.1.4 Rest of World Frozen Donor Egg IVF Cycles Market, By Country
6. GLOBAL DONOR EGG IVF SERVICES MARKET, BY END USER
6.1. OVERVIEW
6.2. FERTILITY CLINICS
6.2.1 FERTILITY CLINICS MARKET, BY REGION
6.2.1.1 North America Fertility Clinics Market, By Country
6.2.1.2 Europe Fertility Clinics Market, By Country
6.2.1.3 Asia-Pacific Fertility Clinics Market, By Country
6.2.1.4 Rest of World Fertility Clinics Market, By Country
6.3. HOSPITALS
6.3.1 HOSPITALS MARKET, BY REGION
6.3.1.1 North America Hospitals Market, By Country
6.3.1.2 Europe Hospitals Market, By Country
6.3.1.3 Asia-Pacific Hospitals Market, By Country
6.3.1.4 Rest of World Hospitals Market, By Country
6.4. SURGICAL CENTERS
6.4.1 SURGICAL CENTERS MARKET, BY REGION
6.4.1.1 North America Surgical Centers Market, By Country
6.4.1.2 Europe Surgical Centers Market, By Country
6.4.1.3 Asia-Pacific Surgical Centers Market, By Country
6.4.1.4 Rest of World Surgical Centers Market, By Country
6.5. CLINICAL RESEARCH INSTITUTES
6.5.1 CLINICAL RESEARCH INSTITUTES MARKET, BY REGION
6.5.1.1 North America Clinical Research Institutes Market, By Country
6.5.1.2 Europe Clinical Research Institutes Market, By Country
6.5.1.3 Asia-Pacific Clinical Research Institutes Market, By Country
6.5.1.4 Rest of World Clinical Research Institutes Market, By Country
7. GLOBAL DONOR EGG IVF SERVICES MARKET, BY REGION
7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1 NORTH AMERICA DONOR EGG IVF SERVICES MARKET, BY CYCLE TYPE
7.2.2 NORTH AMERICA DONOR EGG IVF SERVICES MARKET, BY END USER
7.2.3 NORTH AMERICA DONOR EGG IVF SERVICES, MARKET BY COUNTRY
7.2.3.1 U.S.
7.2.3.1.1 U.S. Donor Egg IVF Services Market, By Cycle Type
7.2.3.1.2 U.S. Donor Egg IVF Services Market, By End User
7.2.3.2 Canada
7.2.3.2.1 Canada Donor Egg IVF Services Market, By Cycle Type
7.2.3.2.2 Canada Donor Egg IVF Services Market, By End User
7.3. EUROPE
7.3.1 EUROPE DONOR EGG IVF SERVICES MARKET, BY CYCLE TYPE
7.3.2 EUROPE DONOR EGG IVF SERVICES MARKET, BY END USER
7.3.3 EUROPE DONOR EGG IVF SERVICES, MARKET BY COUNTRY
7.3.3.1 Ireland
7.3.3.1.1 Ireland Donor Egg IVF Services Market, By Cycle Type
7.3.3.1.2 Ireland Donor Egg IVF Services Market, By End User
7.3.3.2 Germany
7.3.3.2.1 Germany Donor Egg IVF Services Market, By Cycle Type
7.3.3.2.2 Germany Donor Egg IVF Services Market, By End User
7.3.3.3 U.K.
7.3.3.3.1 U.K. Donor Egg IVF Services Market, By Cycle Type
7.3.3.3.2 U.K. Donor Egg IVF Services Market, By End User
7.3.3.4 France
7.3.3.4.1 France Donor Egg IVF Services Market, By Cycle Type
7.3.3.4.2 France Donor Egg IVF Services Market, By End User
7.3.3.5 Rest of Europe
7.3.3.5.1 Rest of Europe Donor Egg IVF Services Market, By Cycle Type
7.3.3.5.2 Rest of Europe Donor Egg IVF Services Market, By End User
7.4. ASIA-PACIFIC
7.4.1 ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET, BY CYCLE TYPE
7.4.2 ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET, BY END USER
7.4.3 ASIA-PACIFIC DONOR EGG IVF SERVICES, MARKET BY COUNTRY
7.4.3.1 Australia
7.4.3.1.1 Australia Donor Egg IVF Services Market, By Cycle Type
7.4.3.1.2 Australia Donor Egg IVF Services Market, By End User
7.4.3.2 New Zealand
7.4.3.2.1 New Zealand Donor Egg IVF Services Market, By Cycle Type
7.4.3.2.2 New Zealand Donor Egg IVF Services Market, By End User
7.4.3.3 Malaysia
7.4.3.3.1 Malaysia Donor Egg IVF Services Market, By Cycle Type
7.4.3.3.2 Malaysia Donor Egg IVF Services Market, By End User
7.4.3.4 Thailand
7.4.3.4.1 Thailand Donor Egg IVF Services Market, By Cycle Type
7.4.3.4.2 Thailand Donor Egg IVF Services Market, By End User
7.4.3.5 Rest of Asia-Pacific
7.4.3.5.1 Rest of Asia-Pacific Donor Egg IVF Services Market, By Cycle Type
7.4.3.5.2 Rest of Asia-Pacific Donor Egg IVF Services Market, By End User
7.5. REST OF WORLD
7.5.1 REST OF WORLD DONOR EGG IVF SERVICES MARKET, BY CYCLE TYPE
7.5.2 REST OF WORLD DONOR EGG IVF SERVICES MARKET, BY END USER
7.5.3 REST OF WORLD DONOR EGG IVF SERVICES, MARKET BY COUNTRY
7.5.3.1 Latin America
7.5.3.1.1 Latin America Donor Egg IVF Services Market, By Cycle Type
7.5.3.1.2 Latin America Donor Egg IVF Services Market, By End User
7.5.3.2 Middle East
7.5.3.2.1 Middle East Donor Egg IVF Services Market, By Cycle Type
7.5.3.2.2 Middle East Donor Egg IVF Services Market, By End User
7.5.3.3 Africa
7.5.3.3.1 Africa Donor Egg IVF Services Market, By Cycle Type
7.5.3.3.2 Africa Donor Egg IVF Services Market, By End User
8. COMPANY PROFILES
8.1. VIRTUS HEALTH
8.1.1 COMPANY OVERVIEW
8.1.2 COMPANY SNAPSHOT
8.1.3 OPERATING BUSINESS SEGMENTS
8.1.4 PRODUCT PORTFOLIO
8.1.5 BUSINESS PERFORMANCE
8.1.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.2. MONASH IVF WESLEY HOSPITAL AUCHENFLOWER
8.2.1 COMPANY OVERVIEW
8.2.2 COMPANY SNAPSHOT
8.2.3 OPERATING BUSINESS SEGMENTS
8.2.4 PRODUCT PORTFOLIO
8.2.5 BUSINESS PERFORMANCE
8.2.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.3. FERTILITY FIRST
8.3.1 COMPANY OVERVIEW
8.3.2 COMPANY SNAPSHOT
8.3.3 OPERATING BUSINESS SEGMENTS
8.3.4 PRODUCT PORTFOLIO
8.3.5 BUSINESS PERFORMANCE
8.3.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.4. FLINDERS REPRODUCTIVE MEDICINE PTY LTD
8.4.1 COMPANY OVERVIEW
8.4.2 COMPANY SNAPSHOT
8.4.3 OPERATING BUSINESS SEGMENTS
8.4.4 PRODUCT PORTFOLIO
8.4.5 BUSINESS PERFORMANCE
8.4.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.5. FERTILITY ASSOCIATES
8.5.1 COMPANY OVERVIEW
8.5.2 COMPANY SNAPSHOT
8.5.3 OPERATING BUSINESS SEGMENTS
8.5.4 PRODUCT PORTFOLIO
8.5.5 BUSINESS PERFORMANCE
8.5.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.6. GENEA OXFORD FERTILITY LIMITED
8.6.1 COMPANY OVERVIEW
8.6.2 COMPANY SNAPSHOT
8.6.3 OPERATING BUSINESS SEGMENTS
8.6.4 PRODUCT PORTFOLIO
8.6.5 BUSINESS PERFORMANCE
8.6.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.7. REPROMED
8.7.1 COMPANY OVERVIEW
8.7.2 COMPANY SNAPSHOT
8.7.3 OPERATING BUSINESS SEGMENTS
8.7.4 PRODUCT PORTFOLIO
8.7.5 BUSINESS PERFORMANCE
8.7.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.8. TRIO FERTILITY
8.8.1 COMPANY OVERVIEW
8.8.2 COMPANY SNAPSHOT
8.8.3 OPERATING BUSINESS SEGMENTS
8.8.4 PRODUCT PORTFOLIO
8.8.5 BUSINESS PERFORMANCE
8.8.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.9. THE MONTREAL FERTILITY CENTER
8.9.1 COMPANY OVERVIEW
8.9.2 COMPANY SNAPSHOT
8.9.3 OPERATING BUSINESS SEGMENTS
8.9.4 PRODUCT PORTFOLIO
8.9.5 BUSINESS PERFORMANCE
8.9.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.10. PROCREA FERTILITY
8.10.1 COMPANY OVERVIEW
8.10.2 COMPANY SNAPSHOT
8.10.3 OPERATING BUSINESS SEGMENTS
8.10.4 PRODUCT PORTFOLIO
8.10.5 BUSINESS PERFORMANCE
8.10.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.11. IVF CANADA
8.11.1 COMPANY OVERVIEW
8.11.2 COMPANY SNAPSHOT
8.11.3 OPERATING BUSINESS SEGMENTS
8.11.4 PRODUCT PORTFOLIO
8.11.5 BUSINESS PERFORMANCE
8.11.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.12. SIMS IVF
8.12.1 COMPANY OVERVIEW
8.12.2 COMPANY SNAPSHOT
8.12.3 OPERATING BUSINESS SEGMENTS
8.12.4 PRODUCT PORTFOLIO
8.12.5 BUSINESS PERFORMANCE
8.12.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.13. MERRION FERTILITY CLINIC
8.13.1 COMPANY OVERVIEW
8.13.2 COMPANY SNAPSHOT
8.13.3 OPERATING BUSINESS SEGMENTS
8.13.4 PRODUCT PORTFOLIO
8.13.5 BUSINESS PERFORMANCE
8.13.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.14. BEACON CARE FERTILITY
8.14.1 COMPANY OVERVIEW
8.14.2 COMPANY SNAPSHOT
8.14.3 OPERATING BUSINESS SEGMENTS
8.14.4 PRODUCT PORTFOLIO
8.14.5 BUSINESS PERFORMANCE
8.14.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.15. MEDFEM FERTILITY CLINIC
8.15.1 COMPANY OVERVIEW
8.15.2 COMPANY SNAPSHOT
8.15.3 OPERATING BUSINESS SEGMENTS
8.15.4 PRODUCT PORTFOLIO
8.15.5 BUSINESS PERFORMANCE
8.15.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.16. THE CAPE FERTILITY CLINIC
8.16.1 COMPANY OVERVIEW
8.16.2 COMPANY SNAPSHOT
8.16.3 OPERATING BUSINESS SEGMENTS
8.16.4 PRODUCT PORTFOLIO
8.16.5 BUSINESS PERFORMANCE
8.16.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.17. AEVITAS FERTILITY CLINIC
8.17.1 COMPANY OVERVIEW
8.17.2 COMPANY SNAPSHOT
8.17.3 OPERATING BUSINESS SEGMENTS
8.17.4 PRODUCT PORTFOLIO
8.17.5 BUSINESS PERFORMANCE
8.17.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.18. DAMAI SERVICE HOSPITAL
8.18.1 COMPANY OVERVIEW
8.18.2 COMPANY SNAPSHOT
8.18.3 OPERATING BUSINESS SEGMENTS
8.18.4 PRODUCT PORTFOLIO
8.18.5 BUSINESS PERFORMANCE
8.18.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.19. TMC FERTILITY CENTRE
8.19.1 COMPANY OVERVIEW
8.19.2 COMPANY SNAPSHOT
8.19.3 OPERATING BUSINESS SEGMENTS
8.19.4 PRODUCT PORTFOLIO
8.19.5 BUSINESS PERFORMANCE
8.19.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.20. KL FERTILITY & GYNECOLOGY CENTRE
8.20.1 COMPANY OVERVIEW
8.20.2 COMPANY SNAPSHOT
8.20.3 OPERATING BUSINESS SEGMENTS
8.20.4 PRODUCT PORTFOLIO
8.20.5 BUSINESS PERFORMANCE
8.20.6 KEY STRATEGIC MOVES AND DEVELOPMENT